LABP - Landos Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LABP is currently covered by 1 analysts with an average price target of $38.75. This is a potential upside of $15.82 (68.99%) from yesterday's end of day stock price of $22.93.

Landos Biopharma's activity chart (see below) currently has 7 price targets and 11 ratings on display. The stock rating distribution of LABP is 100% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 154.5 days.

Highest price target for LABP is $4, Lowest price target is $4, average price target is $38.75.

Most recent stock forecast was given by CHRIS HOWERTON from JEFFERIES on 06-Jan-2023. First documented stock forecast 01-Mar-2021.

Best performing analysts who are covering LABP - Landos Biopharma:

Reuben Garner Jessica Fye Steven Seedhouse Chris Howerton Thomas Smith Prakhar Agrawal

Currently out of the existing stock ratings of LABP, 1 are a SELL (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$14

1 years 11 months 18 days ago
(06-Jan-2023)

1/2 (50%)

$2 (16.67%)

713

Hold

$3

2 years 1 months 13 days ago
(11-Nov-2022)

1/3 (33.33%)

$-7.6 (-71.70%)

87

Buy

2 years 4 months 12 days ago
(12-Aug-2022)

0/1 (0%)

$167.4 (102.95%)

Hold

$15

$8.43 (128.31%)

$170

2 years 11 months 21 days ago
(03-Jan-2022)

1/2 (50%)

$-37.2 (-71.26%)

64

Buy

$45

$41.62 (1231.36%)

$45

3 years 1 months 6 days ago
(18-Nov-2021)

2/2 (100%)

$-53.8 (-54.45%)

63

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LABP (Landos Biopharma) average time for price targets to be met?

On average it took 154.5 days on average for the stock forecasts to be realized with a an average price target met ratio 38.89

Which analyst has the current highest performing score on LABP (Landos Biopharma) with a proven track record?

REUBEN GARNER

Which analyst has the current lower performing score on LABP (Landos Biopharma) with a proven track record?

PRAKHAR AGRAWAL

Which analyst has the most public recommendations on LABP (Landos Biopharma)?

Reuben Garner works at BENCHMARK and has 14 price targets and 8 ratings on LABP

Which analyst is the currently most bullish on LABP (Landos Biopharma)?

Reuben Garner with highest potential upside - $41.62

Which analyst is the currently most reserved on LABP (Landos Biopharma)?

Steven Seedhouse with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?